Perseus Proteomics (4882) · RiskRestated
Risk of Unexpected Costs Associated with Joint Research with a University
First written in FY2022. 2 of 3 entries say "Restated". Latest entry: FY2025.
3entries
4years
0from disclosures
How it moved
Same theme, other companies
Risk of Research Cost Burden and Difficulty Continuing Joint Research with UniversitiesA theme 5 companies write about · 5 as a headwind · 0 as a tailwind
3 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2025RestatedAnnual report
「Research collaboration expenses are determined in consultation with the universities. However, if the circumstances surrounding the research collaboration themes or other factors result in the Company incurring expenses it did not anticipate, this could affect its operating results and financial condition.」
The possibility of incurring unplanned additional costs while continuing joint research with universities has been reconfirmed. - FY2023RestatedAnnual report
「Additional costs may be incurred depending on the progress of the joint research.」
The possibility of incurring unplanned additional costs while continuing joint research with universities has been reconfirmed. - FY2022First statedAnnual report
「If unplanned costs arise depending on the status of themes and other matters related to joint research, they may affect our operating results and financial position.」
Under its policy of continuing joint research with multiple universities, the company identifies as a risk the possibility of incurring additional joint research expenses depending on research progress.